FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer (TOSCA)

This study is currently recruiting participants.
Verified December 2009 by Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Sponsor:
Collaborator:
Mario Negri Institute for Pharmacological Research
Information provided by (Responsible Party):
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
ClinicalTrials.gov Identifier:
NCT00646607
First received: March 17, 2008
Last updated: September 3, 2013
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)